46.70
4.17%
1.87
Handel nachbörslich:
47.25
0.55
+1.18%
Finanzdaten der Agios Pharmaceuticals Inc-Aktie (AGIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
15.29%
8.189
|
7.103 | 7.399 | 6.712 | 5.609 |
Cost Of Revenue |
7.00%
0.627
|
0.586 | 0.633 | 1.108 | 0.554 |
Gross Profit |
16.03%
7.562
|
6.517 | 6.766 | 5.604 | 5.055 |
Operating Expenses
|
11.67%
99.63
|
112.79 | 107.66 | 99.30 | 95.67 |
Benefits Costs and Expenses |
35.52%
100.26
|
73.98 | 108.30 | 100.41 | 96.22 |
Costs And Expenses |
11.57%
100.26
|
113.38 | 108.30 | 100.41 | 96.22 |
Operating Income/Loss |
13.37%
-92.07
|
-106.28 | -100.90 | -93.70 | -90.61 |
Income/Loss From Continuing Operations Before Tax |
37.67%
-92.07
|
-66.88 | -100.90 | -83.81 | -81.02 |
Income/Loss From Continuing Operations After Tax |
15.00%
-81.55
|
-95.94 | -91.32 | -83.81 | -81.02 |
Net Income/Loss
|
15.00%
-81.55
|
-95.94 | -91.32 | -83.81 | -81.02 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
61,373%
56.38
|
0.0917 | 55.80 | 55.60 | 55.27 |
Diluted Average Shares |
61,373%
56.38
|
0.0917 | 55.80 | 55.60 | 55.27 |
Basic Earnings Per Share |
15.70%
-1.45
|
-1.72 | -1.64 | -1.51 | -1.47 |
Diluted Earnings Per Share |
15.70%
-1.45
|
-1.72 | -1.64 | -1.51 | -1.47 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):